![](/img/cover-not-exists.png)
Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry
Hopkin, Robert J., Cabrera, Gustavo, Charrow, Joel, Lemay, Roberta, Martins, Ana Maria, Mauer, Michael, Ortiz, Alberto, Patel, Manesh R., Sims, Katherine, Waldek, Stephen, Warnock, David G., Wilcox, WLanguage:
english
Journal:
Molecular Genetics and Metabolism
DOI:
10.1016/j.ymgme.2016.06.007
Date:
June, 2016
File:
PDF, 1.19 MB
english, 2016